This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 966
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
== Structure == | == Structure == | ||
===Global aspect=== | ===Global aspect=== | ||
| - | The Ramachandran diagram is shown on | + | The Ramachandran diagram is shown on '''Figure 1''' |
{| | {| | ||
| [[Image:ramachandran3BON.png|thumb|'''Figure 1 :''' Ramachandran diagram of C.botulinum neurotoxin serotype A light chain (made using Python by Rémi Pelletier)]] | | [[Image:ramachandran3BON.png|thumb|'''Figure 1 :''' Ramachandran diagram of C.botulinum neurotoxin serotype A light chain (made using Python by Rémi Pelletier)]] | ||
| Line 37: | Line 37: | ||
== Mechanism == | == Mechanism == | ||
[[Image:Mecanismefinal.jpg|left|200px]] | [[Image:Mecanismefinal.jpg|left|200px]] | ||
| + | {{Clear}} | ||
== Therapeutic applications == | == Therapeutic applications == | ||
In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | ||
Revision as of 13:17, 9 January 2015
| This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975. |
To get started:
More help: Help:Editing |
Structure of the "Clostridium botulinum" neurotoxin serotype A light chain with Zn2+ cofactor bound
| |||||||||||
